Prostate cancer hormone therapy tied to higher dementia risk

19 Oct 2016


A study published in JAMA oncology shows that men who are treated with androgen deprivation therapy (ADT) for prostate cancer have an increased risk of developing dementia.

Reuters


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story